Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

B. Kelmendi

14 indexed publications match this author name.

ORCID: 0000-0002-3141-1326
OpenAlex: https://openalex.org/A5110948308

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 8 OCD 7 Chronic Pain 5 Clinical Trial 5 Mechanism of Action 4 Review Article 3 Randomized Controlled Trial 3 Emotional Processing 2 Receptor Pharmacology 2 Adverse Events 2 Depression 2 Healthcare Workers 2

Journals

Frontiers in Psychiatry 3 PsyArXiv 2 JAMA Network Open 1 Drug and Alcohol Dependence 1 JAMA 1 Heliyon 1 BMC palliative care 1

Publication history

Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26 Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04 Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse IndicationsDrug and Alcohol Dependence · 2024-06-30 Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Unknown journal · 2024-02-15 Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08 Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.Unknown journal · 2023-12-31 Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30 Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24 Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCDPsyArXiv · 2023-03-16 Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case reportHeliyon · 2022-11-30 Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355PsyArXiv · 2022-10-04 Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.BMC palliative care · 2021-12-19 The role of psychedelics in palliative care reconsidered: A case for psilocybin.Unknown journal · 2016-11-30

Author directory